“…We also thank the Ministry of Higher Education (Malaysia) for funding structural studies through the High-Impact Research scheme (UM.C/HIR/MOHE/SC/12). Hussainy et al, 2011;Moussa et al, 2011), anti-convulsant (Kamiński et al, 2011, anti-microbial (Sheng et al, 2011), anti-cancer (Yang et al 2011) and histamine antagonist (Liu et al, 2011). In continuation of our interest in the chemical and pharmacological properties of 1,4-piperazine derivatives (Kadi et al, 2010), we synthesized the title compound, (I), as an intermediate for potential chemotherapeutic agents.…”